Insiders BioSenic SA

Equities

Market Closed - Euronext Bruxelles Other stock markets 11:26:36 2024-05-21 am EDT			5-day change	1st Jan Change
0.0177 ^EUR	+7.27%		+22.92%	-71.08%

Apr. 11	Biosenic: launch of a debt restructuring plan	CF
Mar. 12	Biosenic S.A. Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO for Chronic Graft-Versus-Host Disease	CI

BioSenic Names Chief Scientific Officer as COO	Jan. 10	MT
Biosenic S.A. and Its Subsidiary Medsenic SAS Announces the Promotion of Carole Nicco to Chief Operating Officer	Jan. 10	CI
Belgium's BioSenic Appoints New Chief Medical Officer	23-04-03	MT
BioSenic S.A. Appoints Lieven Huysse as Chief Medical Officer, Effective 17 April 2023	23-04-03	CI
BioSenic S.A. Appoints Yves Sagot as Independent Director	23-01-27	CI
BioSenic Names New Chief Scientific Officer	23-01-18	MT
BioSenic Appoints Dr. Carole Nicco as Chief Scientific Officer	23-01-18	CI
BioSenic Names Interim Chief Medical Officer	22-12-02	MT
BioSenic S.A. Appoints Michel Wurm as Interim Chief Medical Officer	22-12-02	CI
Bone Therapeutics To Change Name To BioSenic Following Medsenic Deal	22-10-25	MT
Francois Rieger Joins as CEO of BioSenic SA	22-10-25	CI
BioSenic Announces Management Changes	22-10-25	CI
Bone Therapeutics SA has Changed its Name to BioSenic SA	22-10-25	CI
Bone Therapeutics CEO, Other Executives to Leave Amid Revised Strategy; Shares Down 9%	22-03-29	MT
Bone Therapeutics Appoints Scientific Advisory Board for iMSC Cell and Gene Therapy Platform Development	21-10-12	CI
Hyloris Pharmaceuticals : Appoints New CFO From Bone Therapeutics	21-09-23	MT
Bone Therapeutics : Hires Interim CFO	21-09-21	MT
Bone Therapeutics SA Announces Executive Changes	21-09-21	CI
Bone Therapeutics Appoints Anne Leselbaum, MD as Chief Medical Officer, Effective 23 August 2021	21-07-12	CI
Bone Therapeutics Appoints Anthony Ting as Chief Scientific Officer	21-03-30	CI

No results for this search